Cargando…
The therapeutic efficacy of Chinese patent medicine combined with routine western medicine in the treatment of coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta-analysis
BACKGROUND: Coronavirus disease 2019 (COVID-19) is a potentially fatal disease. clinical practice shows that Chinese Patent Medicine (CPM) has played an important role in the outbreak, Among them, Jinhua Qinggan granules, Lianhua Qingwen capsule, and Xuebiqing injection have an effect in treating CO...
Autores principales: | Zhang, Jingxia, Li, Shasha, Zhao, Chongbo, Wang, Weifeng, Li, Fan, Li, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505289/ https://www.ncbi.nlm.nih.gov/pubmed/32957380 http://dx.doi.org/10.1097/MD.0000000000022277 |
Ejemplares similares
-
Efficacy and safety of Reyanning mixture combined with conventional Western medicine for treating COVID-19: A protocol for systematic review and meta-analysis
por: Li, Yajuan, et al.
Publicado: (2021) -
The therapeutic efficacy of Xuanfei Baidu Formula combined with conventional drug in the treatment of coronavirus disease 2019: A protocol for systematic review and meta-analysis
por: Li, Fan, et al.
Publicado: (2021) -
Traditional Chinese medicine Lianhua Qingwen for treating COVID-19: A protocol for a meta-analysis and systematic review of randomized controlled trials
por: Li, Shasha, et al.
Publicado: (2021) -
Chinese patent medicine (Jinlong Capsule) for gastric cancer: Protocol for a systematic review and meta-analysis
por: Li, Jianwei, et al.
Publicado: (2020) -
Therapeutic efficacy of Chinese patent medicine containing pyrite for fractures: A protocol for systematic review and meta-analysis
por: Choi, Su Hyeon, et al.
Publicado: (2022)